Risk of androgen deprivation therapy after active surveillance for prostate cancer: A real-world analysis

Urologic Oncology: Seminars and Original Investigations · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles